HEADER HYDROLASE 13-AUG-03 1Q6T TITLE THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH TITLE 2 COMPOUND 11 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN; COMPND 5 SYNONYM: PROTEIN-TYROSINE PHOSPHATASE 1B, PTP-1B; COMPND 6 EC: 3.1.3.48; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PTPN1 OR PTP1B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PFLAG-2 KEYWDS PHOSPHATASE, SECONDARY BINDING SITE, SELECTIVITY, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR G.SCAPIN,S.B.PATEL,J.W.BECKER,Q.WANG,C.DESPONTS,D.WADDLETON,K.SKOREY, AUTHOR 2 W.CROMLISH,C.BAYLY,M.THERIEN,J.Y.GAUTHIER,C.S.LI,C.K.LAU, AUTHOR 3 C.RAMACHANDRAN,B.P.KENNEDY,E.ASANTE-APPIAH REVDAT 5 16-AUG-23 1Q6T 1 REMARK SEQADV LINK REVDAT 4 11-OCT-17 1Q6T 1 REMARK REVDAT 3 24-FEB-09 1Q6T 1 VERSN REVDAT 2 14-OCT-03 1Q6T 1 JRNL REVDAT 1 30-SEP-03 1Q6T 0 JRNL AUTH G.SCAPIN,S.B.PATEL,J.W.BECKER,Q.WANG,C.DESPONTS,D.WADDLETON, JRNL AUTH 2 K.SKOREY,W.CROMLISH,C.BAYLY,M.THERIEN,J.Y.GAUTHIER,C.S.LI, JRNL AUTH 3 C.K.LAU,C.RAMACHANDRAN,B.P.KENNEDY,E.ASANTE-APPIAH JRNL TITL THE STRUCTURAL BASIS FOR THE SELECTIVITY OF BENZOTRIAZOLE JRNL TITL 2 INHIBITORS OF PTP1B JRNL REF BIOCHEMISTRY V. 42 11451 2003 JRNL REFN ISSN 0006-2960 JRNL PMID 14516196 JRNL DOI 10.1021/BI035098J REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 12.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.4 REMARK 3 NUMBER OF REFLECTIONS : 46901 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.214 REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2375 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 48164 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.40 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4167 REMARK 3 BIN R VALUE (WORKING SET) : 0.2680 REMARK 3 BIN FREE R VALUE : 0.3210 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 210 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4695 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 118 REMARK 3 SOLVENT ATOMS : 205 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 38.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 5.07800 REMARK 3 B22 (A**2) : 0.82400 REMARK 3 B33 (A**2) : -5.90200 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM SIGMAA (A) : 0.25 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.34 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.31 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.836 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.250 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.640 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.150 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.450 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : MASK REMARK 3 KSOL : 0.39 REMARK 3 BSOL : 48.73 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1Q6T COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-AUG-03. REMARK 100 THE DEPOSITION ID IS D_1000019988. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-FEB-00 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NA REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : X-GEN REMARK 200 DATA SCALING SOFTWARE : X-GEN REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 48228 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 28.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 5.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05800 REMARK 200 FOR THE DATA SET : 11.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.44 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.1 REMARK 200 DATA REDUNDANCY IN SHELL : 5.92 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.32400 REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNX REMARK 200 STARTING MODEL: PDB ENTRY 1Q6S REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 66.79 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, MGCL2, HEPES, PH 7.00, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 44.01450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 69.46300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.91400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 69.46300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 44.01450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.91400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 489 REMARK 465 ASP A 490 REMARK 465 TYR A 491 REMARK 465 LYS A 492 REMARK 465 ASP A 493 REMARK 465 ASP A 494 REMARK 465 ASP A 495 REMARK 465 ASP A 496 REMARK 465 SER A 786 REMARK 465 VAL A 787 REMARK 465 GLN A 788 REMARK 465 ASP A 789 REMARK 465 GLN A 790 REMARK 465 TRP A 791 REMARK 465 LYS A 792 REMARK 465 GLU A 793 REMARK 465 LEU A 794 REMARK 465 SER A 795 REMARK 465 HIS A 796 REMARK 465 GLU A 797 REMARK 465 ASP A 798 REMARK 465 MET B 989 REMARK 465 ASP B 990 REMARK 465 TYR B 991 REMARK 465 LYS B 992 REMARK 465 ASP B 993 REMARK 465 ASP B 994 REMARK 465 ASP B 995 REMARK 465 ASP B 996 REMARK 465 SER B 1286 REMARK 465 VAL B 1287 REMARK 465 GLN B 1288 REMARK 465 ASP B 1289 REMARK 465 GLN B 1290 REMARK 465 TRP B 1291 REMARK 465 LYS B 1292 REMARK 465 GLU B 1293 REMARK 465 LEU B 1294 REMARK 465 SER B 1295 REMARK 465 HIS B 1296 REMARK 465 GLU B 1297 REMARK 465 ASP B 1298 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 497 CG CD CE NZ REMARK 470 LEU A 498 CG CD1 CD2 REMARK 470 MET A 501 CG SD CE REMARK 470 LYS B 997 CG CD CE NZ REMARK 470 LEU B 998 CG CD1 CD2 REMARK 470 MET B1001 CG SD CE REMARK 470 MET B1114 CG SD CE REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP B1063 CA - CB - CG ANGL. DEV. = -22.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 498 39.26 -89.36 REMARK 500 ASP A 563 -71.42 -61.64 REMARK 500 GLU A 575 -78.82 -46.38 REMARK 500 SER A 618 102.98 -164.84 REMARK 500 LEU A 619 95.64 -49.80 REMARK 500 CYS A 621 136.09 -176.81 REMARK 500 LYS A 631 71.22 -115.14 REMARK 500 GLN A 666 18.37 59.83 REMARK 500 CYS A 715 -129.20 -134.80 REMARK 500 ILE A 719 -39.62 -133.13 REMARK 500 ILE A 761 110.89 78.92 REMARK 500 ASP B1011 98.83 -41.89 REMARK 500 LYS B1012 137.31 -174.37 REMARK 500 GLN B1061 -149.17 -59.01 REMARK 500 GLU B1062 -169.99 -65.23 REMARK 500 ASP B1063 -70.57 -40.57 REMARK 500 ASN B1111 -167.06 -116.86 REMARK 500 LYS B1116 -90.00 -40.90 REMARK 500 LYS B1131 72.53 -108.86 REMARK 500 CYS B1215 -137.82 -135.16 REMARK 500 ILE B1261 111.53 79.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A6000 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH A6001 O REMARK 620 2 HOH A6002 O 82.4 REMARK 620 3 HOH A6003 O 63.4 71.2 REMARK 620 4 HOH A6004 O 88.2 90.9 147.6 REMARK 620 5 HOH A6005 O 137.5 68.3 78.1 121.0 REMARK 620 6 HOH A6006 O 108.8 130.8 72.2 135.7 72.9 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B5000 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B1054 O REMARK 620 2 HOH B5001 O 65.8 REMARK 620 3 HOH B5002 O 86.5 67.3 REMARK 620 4 HOH B5003 O 65.9 131.0 116.8 REMARK 620 5 HOH B5004 O 126.7 66.5 53.8 158.6 REMARK 620 6 HOH B5005 O 118.7 85.7 131.8 111.1 79.3 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 5000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 6000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 600 A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 600 B 1301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1Q6J RELATED DB: PDB REMARK 900 SAME PROTEIN IN COMPLEX WITH [4-(2-(1H-1,2,3-BENZOTRIAZOL-1-YL)-3-{ REMARK 900 4-[DIFLUORO(PHOSPHONO)METHYL]PHENYL}-2-PHENYLPROPYL)PHENYL] REMARK 900 (DIFLUORO)METHYLPHOSPHONIC ACID REMARK 900 RELATED ID: 1Q6M RELATED DB: PDB REMARK 900 SAME PROTEIN IN COMPLEX WITH {[2-(1H-1,2,3-BENZOTRIAZOL-1-YL)-2-(3, REMARK 900 4-DIFLUOROPHENYL)PROPANE-1,3-DIYL]BIS[4,1- REMARK 900 PHENYLENE(DIFLUOROMETHYLENE)]}BISPHOSPHONIC ACID REMARK 900 RELATED ID: 1Q6N RELATED DB: PDB REMARK 900 SAME PROTEIN IN COMPLEX WITH {4-[(2S,4E)-2-(1,3-BENZOTHIAZOL-2-YL)- REMARK 900 2-(1H-1,2,3-BENZOTRIAZOL-1-YL)-5-PHENYLPENT-4-ENYL]PHENYL}(DIFLUORO) REMARK 900 METHYLPHOSPHONIC ACID REMARK 900 RELATED ID: 1Q6P RELATED DB: PDB REMARK 900 SAME PROTEIN IN COMPLEX WITH [{4-[(4E)-2-(1,3-BENZOTHIAZOL-2-YL)-2- REMARK 900 (1H-1,2,3-BENZOTRIAZOL-1-YL)-5-PHENYLPENT-4-EN-1-YL]PHENYL} REMARK 900 (DIFLUORO)METHYL]PHOSPHONIC ACID REMARK 900 RELATED ID: 1Q6S RELATED DB: PDB REMARK 900 SAME PROTEIN IN COMPLEX WITH {6-[4-(2-(1H-1,2,3-BENZOTRIAZOL-1-YL)- REMARK 900 3-{4-[DIFLUORO(PHOSPHONO)METHYL]PHENYL}-2-PHENYLPROPYL)PHENYL]-2- REMARK 900 METHYLQUINOLIN-8-YL}PHOSPHONIC ACID DBREF 1Q6T A 501 798 UNP P18031 PTN1_HUMAN 1 298 DBREF 1Q6T B 1001 1298 UNP P18031 PTN1_HUMAN 1 298 SEQADV 1Q6T MET A 489 UNP P18031 CLONING ARTIFACT SEQADV 1Q6T ASP A 490 UNP P18031 CLONING ARTIFACT SEQADV 1Q6T TYR A 491 UNP P18031 CLONING ARTIFACT SEQADV 1Q6T LYS A 492 UNP P18031 CLONING ARTIFACT SEQADV 1Q6T ASP A 493 UNP P18031 CLONING ARTIFACT SEQADV 1Q6T ASP A 494 UNP P18031 CLONING ARTIFACT SEQADV 1Q6T ASP A 495 UNP P18031 CLONING ARTIFACT SEQADV 1Q6T ASP A 496 UNP P18031 CLONING ARTIFACT SEQADV 1Q6T LYS A 497 UNP P18031 CLONING ARTIFACT SEQADV 1Q6T LEU A 498 UNP P18031 CLONING ARTIFACT SEQADV 1Q6T GLU A 499 UNP P18031 CLONING ARTIFACT SEQADV 1Q6T PHE A 500 UNP P18031 CLONING ARTIFACT SEQADV 1Q6T MET B 989 UNP P18031 CLONING ARTIFACT SEQADV 1Q6T ASP B 990 UNP P18031 CLONING ARTIFACT SEQADV 1Q6T TYR B 991 UNP P18031 CLONING ARTIFACT SEQADV 1Q6T LYS B 992 UNP P18031 CLONING ARTIFACT SEQADV 1Q6T ASP B 993 UNP P18031 CLONING ARTIFACT SEQADV 1Q6T ASP B 994 UNP P18031 CLONING ARTIFACT SEQADV 1Q6T ASP B 995 UNP P18031 CLONING ARTIFACT SEQADV 1Q6T ASP B 996 UNP P18031 CLONING ARTIFACT SEQADV 1Q6T LYS B 997 UNP P18031 CLONING ARTIFACT SEQADV 1Q6T LEU B 998 UNP P18031 CLONING ARTIFACT SEQADV 1Q6T GLU B 999 UNP P18031 CLONING ARTIFACT SEQADV 1Q6T PHE B 1000 UNP P18031 CLONING ARTIFACT SEQRES 1 A 310 MET ASP TYR LYS ASP ASP ASP ASP LYS LEU GLU PHE MET SEQRES 2 A 310 GLU MET GLU LYS GLU PHE GLU GLN ILE ASP LYS SER GLY SEQRES 3 A 310 SER TRP ALA ALA ILE TYR GLN ASP ILE ARG HIS GLU ALA SEQRES 4 A 310 SER ASP PHE PRO CYS ARG VAL ALA LYS LEU PRO LYS ASN SEQRES 5 A 310 LYS ASN ARG ASN ARG TYR ARG ASP VAL SER PRO PHE ASP SEQRES 6 A 310 HIS SER ARG ILE LYS LEU HIS GLN GLU ASP ASN ASP TYR SEQRES 7 A 310 ILE ASN ALA SER LEU ILE LYS MET GLU GLU ALA GLN ARG SEQRES 8 A 310 SER TYR ILE LEU THR GLN GLY PRO LEU PRO ASN THR CYS SEQRES 9 A 310 GLY HIS PHE TRP GLU MET VAL TRP GLU GLN LYS SER ARG SEQRES 10 A 310 GLY VAL VAL MET LEU ASN ARG VAL MET GLU LYS GLY SER SEQRES 11 A 310 LEU LYS CYS ALA GLN TYR TRP PRO GLN LYS GLU GLU LYS SEQRES 12 A 310 GLU MET ILE PHE GLU ASP THR ASN LEU LYS LEU THR LEU SEQRES 13 A 310 ILE SER GLU ASP ILE LYS SER TYR TYR THR VAL ARG GLN SEQRES 14 A 310 LEU GLU LEU GLU ASN LEU THR THR GLN GLU THR ARG GLU SEQRES 15 A 310 ILE LEU HIS PHE HIS TYR THR THR TRP PRO ASP PHE GLY SEQRES 16 A 310 VAL PRO GLU SER PRO ALA SER PHE LEU ASN PHE LEU PHE SEQRES 17 A 310 LYS VAL ARG GLU SER GLY SER LEU SER PRO GLU HIS GLY SEQRES 18 A 310 PRO VAL VAL VAL HIS CYS SER ALA GLY ILE GLY ARG SER SEQRES 19 A 310 GLY THR PHE CYS LEU ALA ASP THR CYS LEU LEU LEU MET SEQRES 20 A 310 ASP LYS ARG LYS ASP PRO SER SER VAL ASP ILE LYS LYS SEQRES 21 A 310 VAL LEU LEU GLU MET ARG LYS PHE ARG MET GLY LEU ILE SEQRES 22 A 310 GLN THR ALA ASP GLN LEU ARG PHE SER TYR LEU ALA VAL SEQRES 23 A 310 ILE GLU GLY ALA LYS PHE ILE MET GLY ASP SER SER VAL SEQRES 24 A 310 GLN ASP GLN TRP LYS GLU LEU SER HIS GLU ASP SEQRES 1 B 310 MET ASP TYR LYS ASP ASP ASP ASP LYS LEU GLU PHE MET SEQRES 2 B 310 GLU MET GLU LYS GLU PHE GLU GLN ILE ASP LYS SER GLY SEQRES 3 B 310 SER TRP ALA ALA ILE TYR GLN ASP ILE ARG HIS GLU ALA SEQRES 4 B 310 SER ASP PHE PRO CYS ARG VAL ALA LYS LEU PRO LYS ASN SEQRES 5 B 310 LYS ASN ARG ASN ARG TYR ARG ASP VAL SER PRO PHE ASP SEQRES 6 B 310 HIS SER ARG ILE LYS LEU HIS GLN GLU ASP ASN ASP TYR SEQRES 7 B 310 ILE ASN ALA SER LEU ILE LYS MET GLU GLU ALA GLN ARG SEQRES 8 B 310 SER TYR ILE LEU THR GLN GLY PRO LEU PRO ASN THR CYS SEQRES 9 B 310 GLY HIS PHE TRP GLU MET VAL TRP GLU GLN LYS SER ARG SEQRES 10 B 310 GLY VAL VAL MET LEU ASN ARG VAL MET GLU LYS GLY SER SEQRES 11 B 310 LEU LYS CYS ALA GLN TYR TRP PRO GLN LYS GLU GLU LYS SEQRES 12 B 310 GLU MET ILE PHE GLU ASP THR ASN LEU LYS LEU THR LEU SEQRES 13 B 310 ILE SER GLU ASP ILE LYS SER TYR TYR THR VAL ARG GLN SEQRES 14 B 310 LEU GLU LEU GLU ASN LEU THR THR GLN GLU THR ARG GLU SEQRES 15 B 310 ILE LEU HIS PHE HIS TYR THR THR TRP PRO ASP PHE GLY SEQRES 16 B 310 VAL PRO GLU SER PRO ALA SER PHE LEU ASN PHE LEU PHE SEQRES 17 B 310 LYS VAL ARG GLU SER GLY SER LEU SER PRO GLU HIS GLY SEQRES 18 B 310 PRO VAL VAL VAL HIS CYS SER ALA GLY ILE GLY ARG SER SEQRES 19 B 310 GLY THR PHE CYS LEU ALA ASP THR CYS LEU LEU LEU MET SEQRES 20 B 310 ASP LYS ARG LYS ASP PRO SER SER VAL ASP ILE LYS LYS SEQRES 21 B 310 VAL LEU LEU GLU MET ARG LYS PHE ARG MET GLY LEU ILE SEQRES 22 B 310 GLN THR ALA ASP GLN LEU ARG PHE SER TYR LEU ALA VAL SEQRES 23 B 310 ILE GLU GLY ALA LYS PHE ILE MET GLY ASP SER SER VAL SEQRES 24 B 310 GLN ASP GLN TRP LYS GLU LEU SER HIS GLU ASP HET MG A6000 1 HET 600 A 801 58 HET MG B5000 1 HET 600 B1301 58 HETNAM MG MAGNESIUM ION HETNAM 600 6-[4-((2S)-2-(1H-1,2,3-BENZOTRIAZOL-1-YL)-3-{4- HETNAM 2 600 [DIFLUORO(PHOSPHONO)METHYL]PHENYL}-2-PHENYLPROPYL) HETNAM 3 600 PHENYL]-2-[(1S)-1-METHOXY-3-METHYLBUTYL]QUINOLIN-8- HETNAM 4 600 YLPHOSPHONIC ACID FORMUL 3 MG 2(MG 2+) FORMUL 4 600 2(C43 H42 F2 N4 O7 P2) FORMUL 7 HOH *205(H2 O) HELIX 1 1 GLU A 499 GLY A 514 1 16 HELIX 2 2 SER A 515 HIS A 525 1 11 HELIX 3 3 LEU A 537 ASN A 544 5 8 HELIX 4 4 PHE A 552 HIS A 554 5 3 HELIX 5 5 THR A 591 GLN A 602 1 12 HELIX 6 6 SER A 687 SER A 701 1 15 HELIX 7 7 ILE A 719 ARG A 738 1 20 HELIX 8 8 ASP A 740 VAL A 744 5 5 HELIX 9 9 ASP A 745 ARG A 754 1 10 HELIX 10 10 THR A 763 GLY A 783 1 21 HELIX 11 11 LEU B 998 ASP B 1011 1 14 HELIX 12 12 LYS B 1012 ALA B 1027 1 16 HELIX 13 13 LEU B 1037 ASN B 1044 5 8 HELIX 14 14 PHE B 1052 ARG B 1056 5 5 HELIX 15 15 THR B 1091 GLN B 1102 1 12 HELIX 16 16 SER B 1187 SER B 1201 1 15 HELIX 17 17 GLY B 1220 ARG B 1238 1 19 HELIX 18 18 ASP B 1240 VAL B 1244 5 5 HELIX 19 19 ASP B 1245 ARG B 1254 1 10 HELIX 20 20 THR B 1263 GLY B 1283 1 21 SHEET 1 A 9 ARG A 556 LYS A 558 0 SHEET 2 A 9 TYR A 566 MET A 574 -1 O ALA A 569 N ILE A 557 SHEET 3 A 9 ARG A 579 THR A 584 -1 O LEU A 583 N SER A 570 SHEET 4 A 9 VAL A 711 HIS A 714 1 O VAL A 713 N ILE A 582 SHEET 5 A 9 GLY A 606 MET A 609 1 N VAL A 608 O VAL A 712 SHEET 6 A 9 GLU A 667 TYR A 676 1 O TYR A 676 N MET A 609 SHEET 7 A 9 TYR A 653 ASN A 662 -1 N THR A 654 O HIS A 675 SHEET 8 A 9 LEU A 640 ILE A 649 -1 N SER A 646 O GLN A 657 SHEET 9 A 9 MET A 633 PHE A 635 -1 N MET A 633 O LEU A 642 SHEET 1 B 8 ALA B1069 MET B1074 0 SHEET 2 B 8 ARG B1079 THR B1084 -1 O ARG B1079 N MET B1074 SHEET 3 B 8 VAL B1211 HIS B1214 1 O VAL B1213 N ILE B1082 SHEET 4 B 8 GLY B1106 MET B1109 1 N VAL B1108 O VAL B1212 SHEET 5 B 8 THR B1168 TYR B1176 1 O PHE B1174 N MET B1109 SHEET 6 B 8 TYR B1153 ASN B1162 -1 N ARG B1156 O HIS B1173 SHEET 7 B 8 LEU B1140 ILE B1149 -1 N SER B1146 O GLN B1157 SHEET 8 B 8 MET B1133 PHE B1135 -1 N MET B1133 O LEU B1142 LINK MG MG A6000 O HOH A6001 1555 1555 2.03 LINK MG MG A6000 O HOH A6002 1555 1555 2.01 LINK MG MG A6000 O HOH A6003 1555 1555 2.61 LINK MG MG A6000 O HOH A6004 1555 1555 2.48 LINK MG MG A6000 O HOH A6005 1555 1555 2.68 LINK MG MG A6000 O HOH A6006 1555 1555 1.91 LINK O HIS B1054 MG MG B5000 4456 1555 3.06 LINK MG MG B5000 O HOH B5001 1555 1555 2.70 LINK MG MG B5000 O HOH B5002 1555 1555 2.11 LINK MG MG B5000 O HOH B5003 1555 1555 1.89 LINK MG MG B5000 O HOH B5004 1555 1555 2.86 LINK MG MG B5000 O HOH B5005 1555 1555 1.89 SITE 1 AC1 6 HIS B1054 HOH B5001 HOH B5002 HOH B5003 SITE 2 AC1 6 HOH B5004 HOH B5005 SITE 1 AC2 7 HIS A 554 HOH A6001 HOH A6002 HOH A6003 SITE 2 AC2 7 HOH A6004 HOH A6005 HOH A6006 SITE 1 AC3 27 HOH A 25 HOH A 30 HOH A 43 HOH A 184 SITE 2 AC3 27 ARG A 524 SER A 528 ASP A 529 TYR A 546 SITE 3 AC3 27 ARG A 547 ASP A 548 PHE A 552 ASP A 681 SITE 4 AC3 27 PHE A 682 CYS A 715 SER A 716 ALA A 717 SITE 5 AC3 27 GLY A 718 ILE A 719 GLY A 720 ARG A 721 SITE 6 AC3 27 ARG A 754 MET A 758 GLN A 762 GLY B1014 SITE 7 AC3 27 ALA B1018 GLN B1021 ASP B1022 SITE 1 AC4 25 ALA A 518 ASP A 522 HIS A 525 GLU A 526 SITE 2 AC4 25 HOH B 79 HOH B 84 HOH B 183 ARG B1024 SITE 3 AC4 25 SER B1028 ASP B1029 TYR B1046 ARG B1047 SITE 4 AC4 25 ASP B1048 PHE B1182 CYS B1215 SER B1216 SITE 5 AC4 25 ALA B1217 GLY B1218 ILE B1219 GLY B1220 SITE 6 AC4 25 ARG B1221 ARG B1254 MET B1258 GLY B1259 SITE 7 AC4 25 GLN B1262 CRYST1 88.029 87.828 138.926 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011360 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011386 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007198 0.00000